To break it down: The first part of the name, HER2, stands for “human epidermal growth factor receptor 2.” This refers to a protein found on the surface of breast cells that helps direct how quickly ...

Most types of breast cancer produce similar symptoms and are discovered the same way—finding a strange new lump during a self-exam, or a healthcare provider spotting something suspicious during a ...

Jenna Fischer, who starred in "The Office," said Tuesday that she underwent surgery and treatment for breast cancer earlier this year and is now "cancer free." Fischer, 50, wrote in an Instagram post ...

Phase II Study of Sequential Administration of Docetaxel Followed by Doxorubicin and Cyclophosphamide as First-Line Chemotherapy in Metastatic Breast Cancer PURPOSE: Few studies have examined the ...

Breast cancer types include IDC, ILC, HR+, HER2-positive, and triple-negative, each with distinct characteristics and treatment implications. Staging from 0 to IV helps determine treatment plans and ...

Nat Clin Pract Oncol. 2008;5(9):531-542. The authors declared no competing interests. Cite this: The Role of Hormonal Therapy in the Management of Hormonal-Receptor-Positive Breast Cancer With ...

Impact of Bone Metastasis in Stage IV Non–Small Cell Lung Cancer Treated With Durvalumab and Tremelimumab With or Without Chemotherapy: A Retrospective Analysis of the CCTG BR.34 Trial Human epidermal ...

Some breast cancers “feed” on the hormone estrogen. These are usually treated with medicines that either block estrogen’s signal (fulvestrant) or slow the cancer’s growth cycle (palbociclib). In about ...

Onco360(R) , the nation's leading independent Specialty Pharmacy, has been selected as the national pharmacy partner by Bayer Pharmaceuticals for HYRNUO(R) (sevabertinib). The Food and Drug ...

Zanidatamab, a bispecific HER2-targeted antibody, delivered clinically meaningful and durable responses for patients with ...

The MHRA has approved inavolisib for adults with PIK3CA-mutated HR+/HER2– breast cancer, offering a new targeted first-line ...

Veru’s breast cancer pipeline includes: enobosarm, an oral, first-in-class, new chemical entity, selective androgen receptor agonist that targets the androgen receptor, a tumor suppressor, to treat ...